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RA = Rheumatoid Arthritis 
JA = Juvenile Arthritis 
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PAF = Platelet-Activating Factor 
CD = Cluster Designation
CCP = Cyclic Citrullinated Protein 
RF     = Rheumatoid Factor
TNF-α = Tumor Necrosis Factor
IL     = Interleukin
cAMP = Cyclic Adenosine Monophosphate
APC = Antigen-Presenting Cells 
IFN   = Interferon 
RANKL = Receptor activator for nuclear kappa k B ligand
PUFA = Polyunsaturated Fatty Acids
OS = Oxidative Stress 
ROS = Reactive Oxygen Species 
NAG = N – Acetyl Glucosaminidase 
CFA = Complete Freund’s adjuvant
NSAIDs = Non steroidal Anti-Inflammatory Drugs
RER = Rough Endoplasmic Reticulum 
NO   = Nitric Oxide
ATP = Adenosine Tri-Phosphate 
DNA = De-oxy Ribonucleic Acid 
MHC = Major -Histocompatibility Complex 
NADPH = Nicotinamide Adenide Dinucleotide Phosphate 
SOD = Super oxide Dismutase
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INTRODUCTION
The  Indian  health  care  scene  has  inherited  a  large  number  of  traditional 
practices, systems, and medicines as part of its total health care scenario, some of them 
more than 10000 years old. The earliest mention of the medicinal use of plants is to be 
found  in  the  Rig-Veda  which  dates  back  as  early  as  3500  BC.  Even  though  the 
modified systems of medicine include Ayurveda, Siddha, Unani and Tibetan; allopathic 
system medicine is the back bone of present medicine systems. It has been developed 
throughout  meticulous  scientific  practices  and  fairly,  effectual  but  still  it  have  a 
tendency to show various type of adverse drug responses and have need of marvelous 
researches on this field. However on the other hand, the natural products, being the 
most  significant  source of  therapeutics,  is  still  at  formative  years  and require  more 
research’s to make it more effective and safer as compared to the existing form.
Ayurveda,  which is considered as an upaveda (or the supplementary Hymns 
designed for more detailed in structure of the humankind), is the very strong foundation 
stone of the ancient medical science of India. From the vast array of the materia medica 
of indigenous it is thought that investigation and research on medicinal plants might 
bring  to  the  scientific  world  many  useful  remedies  for  the  alleviation  of  human 
sufferings. Inspite of the remarkable achievements of modern medicine and medical 
research, these ancient systems continue to be a major component, “effectively” used in 
the control or alleviation of diseases. 
Based on the strong traditional knowledge on the use of plants as therapeutic 
agents, a rational approach is being developed to use medicinal plants as lead for the 
discovery of active molecules, with one of the largest reservoirs of bio-resources. It is 
imperative that India develops a concerted, integrated, structural, and modern approach 
in  this  area  and gains  a  competitive  edge  in  the  international  market  place  for  the 
discovery  and  development  of  Natural  drugs  for  a  variety  of  diseases  for  which 
currently  appropriate  remedies  are  not  available.  All  over  World,  several 
pharmaceutical companies and research organizations are concentrating on the cosmic 
untapped potential of herbals as potential drugs.
Indian systems of Medicine mainly focus on herbal medicines for prevention of 
diseases, to increase the prolonged existence and for heal of chronic diseases. India has 
very flourishing resources of medicinal plants due to wide bio- diversity.  There has 
been  a  prominent  raise  in  utilization  of  herbal  drugs  in  both  developing  and  the 
developed countries due there natural origin and minimal or no side effect. 
Several  important  constituents  of  plant  origin  such  as  alkaloids,  glycosides, 
terpenoids, flavonoids, antibiotics etc. have been isolated and used as the therapeutic 
purposes. It is very important that India develops a concerted, integrated, structural, and 
modern approach in research area and gains a competitive edge in the international 
market  place  for  the  discovery  and development  of  Natural  drugs  for  a  variety  of 
diseases for which currently appropriate remedies are not available for cure them.
According  to  WHO,  traditional  medicine  is  defined  as  health  practices, 
approaches,  knowledge  and  beliefs  incorporating  plant,  animal  and  mineral  based 
medicines, spiritual therapies, manuals techniques and exercises applied as singularly 
or in combination to treat, diagnose and prevent illnesses or maintain well being. The 
term traditional medicine is applied due to the fact  that  they had their origin in the 
remote past and most of these are still practiced almost in the same approach as have 
been in the ancient times, maintaining the tradition. The basic principles involved in 
traditional  system of  medicine  are  that  these  are  holistic  in  nature  and  rather  than 
treating in isolation, they are believed to eradicate the root cause of the disease.
Arthritis
Arthritis is a group of conditions that affects the health of the joints in the body 
particularly the bones of the hands and feet,  which causes pain,  swelling,  stiffness, 
redness,  and  heat.  Arthritis  as  the  name suggest,  means  “joint  inflammation”  from 
(arthro - joints + itis - inflammation; plural: arthritis).  Nearly 100 different types of 
arthritis has already been reported which affects different areas of the body and all age 
groups. Arthritis is the leading cause of disability in humans mostly over 55 years of 
age with certain exceptional cases where the patient may be obese.
Figure-1: Comparison of Normal and Arthritic joint
Common types of Arthritis 
• Rheumatoid  arthritis:  -  Rheumatoid  arthritis  (RA)  is  a  state  of  chronic, 
progressive, inflammatory,  multisystem,  autoimmune disorder,  commonly 
polyarticular, which attacks multiple joints especially smaller joints  of the 
hands and feet.
• Osteoarthritis: - Osteoarthritis also called "wear and tear" arthritis involves 
the gradual deterioration of cartilage usually in the larger, weight-bearing 
joints, which ultimately leads to trauma of joint.
Other types of Arthritis
• Juvenile  arthritis:  -  Juvenile  arthritis  (JA),  also  called  as  Juvenile 
Rheumatoid Arthritis, refers to numerous childhood conditions that involve 
joint pain and inflammation, usually persisting for more than six weeks.
• Ankylosing  spondylitis:  - Ankylosing  spondylitis  (AS)  is  a  form  of 
Spondyloarthritis,  which  primarily  causes  eventual  fusion  of  spine. 
Complete fusion however results in complete rigidity of the spine (bamboo 
spine).
• Septic  arthritis:  -  Septic  arthritis,  also  known  as  infectious  arthritis, 
represents  a  direct  invasion  of  joint  space  by  various  microorganisms, 
including bacteria, viruses, mycobacteria, and fungi.
Rheumatoid arthritis
Rheumatoid  arthritis  is  an  inflammatory  autoimmune  disease  that  is 
characterized by the destruction of joint cartilage and inflammation of the synovium 
(joint fluid) It affects particularly the joints of the ankles and toes, which  causes soft 
tissue swellings (Blake & Lunce, 1985), and synovitis,  which is the hallmark of an 
inflammatory arthritis such as rheumatoid arthritis. Although rheumatoid arthritis most 
often affects the joints, it can also affect many organs and body systems in the body. 
Systemic complications include damage to various organs (lungs, pleura, pericardium, 
myocardium, eyes, and central nervous system) due to inflammatory reactions. As the 
disease progresses, osteoporosis of the contiguous bone, destruction of joint cartilage, 
bone resorption, and displacement by ankylosis occur. 
Inflammation as in the case of rheumatoid arthritis has three different phases: 
• The first phase shows increase of vascular permeability.
• The  second  phase  involves  exudation  of  fluid  from  the  blood  into  the 
tissues.
• The third phase leads to granuloma formation (Jasin, 2005). 
Accordingly,  anti-inflammatory  test  is  divided  into  those  measuring  acute 
inflammation, sub acute inflammation, and chronic repair processes. These studies are 
aimed to  find out new drugs against  polyarthritis  and other rheumatic  diseases.  An 
array  of  physiological  substances,  called  autacoids,  are  involved  in  the  process  of 
inflammation  and  repair.  Some  of  these  include  histamine,  serotonin,  bradykinin, 
substances P, group of Eicosanoids (prostaglandins, thromboxanes and leucotrienes), 
and the platelet-activating  factor  (PAF) as well  as  few cytokines  and lymphokines. 
Rheumatoid  Arthritis  is  2  to  3  times  more  common  in  women  than  in  men,  and 
generally affects people between the ages of 20 and 50. Odema marks the onset of 
Rheumatoid arthritis exhibiting the early stages, which is manifested by joint swelling 
and pain.
Signs and Symptoms of Arthritis
Rheumatoid arthritis usually affects the joints of the hands (such as the knuckle 
joints),  wrists,  elbows,  knees,  ankles,  and/or  feet.  The  larger  joints,  such  as  the 
shoulders, hips, and jaw may be affected.
The usual joint symptoms include the following: -
Stiffness: The joint does not move as well as it once did. Its range of motion 
(the extent to which the appendage of the joint, such as the arm, leg, or finger, 
can move in different directions) may be reduced. 
• Inflammation: Redness,  tenderness,  and  warmth  are  the  hallmarks  of 
inflammation.
• Swelling: The area around the affected joint is swollen and puffy.
• Nodules: These hard bumps appear on or near the joint. They often are found 
near the elbows. They are most noticeable on the part of the joint that juts out 
when the joint is flexed.
• Pain: Pain in rheumatoid arthritis can come from inflammation or swelling of 
the joint and surrounding tissues or from working the joint too hard.
Pathogenesis of Rheumatoid arthritis
Rheumatoid arthritis mostly affects joints where cartilage overlies the bone and 
with a joint cavity lined by synovial membrane that contains synovial fluid. There are 
two popular theories that explain the pathogenesis of rheumatoid arthritis (RA). The 
first theory states that the T cell interacts with an unidentified antigen and acts as the 
primary cell  responsible for initiating the disease as well  as for driving the chronic 
inflammatory process. 
This theory is  based upon the known association of RA with class II major 
histocompatability  antigens,  the  large  number  of  CD4+ T cells  and  skewed  T cell 
receptor gene usage in the RA synovium.
Figure-2: Role of Macrophages and CD4+ T cell in pathogenesis of Arthritis
The second theory holds that, while T cells may be important in initiating the 
disease, chronic inflammation is self-perpetuated by macrophages and fibroblasts in a 
T-cell independent manner. This theory is based upon the relative absence of activated 
T cells phenotypes in chronic RA and the preponderance of activated macrophage and 
fibroblast phenotypes.
Macrophages  play  the  most  important  role  in  secretion  of  RF,  antibodies, 
cytokines,  anti  CCP. This leads to change in synovium of RA due to infiltration of 
macrophages,  T  cell  and  B cell  as  well  pannus  formation  that  leads  to,  erode  the 
articular cartilage and bone and finally destruction of joint occurs. 
Cytokines have a wide range of activity in rheumatoid joint and it shows painful 
inflammatory signs and symptoms of RA. It is believed that they play a vital role in 
both  physiological  and  pathological  regulation  of  bone.  These  pro-inflammatory 
cytokines and proteolytic enzyme act as mediators in RA and it plays an important role 
in  pannus  formation,  proliferation  of  synovial  cells  and  destruction  of  bone  and 
cartilage.  Cytokines  can  induce  oxidative  stress  while  oxidative  stress  can  increase 
levels  of pro-inflammatory cytokines.  It is well known that leucocytes produce pro-
inflammatory cytokines such as TNF-α  and IL-6, which play important roles in both 
RA in humans and AA in rats (Silva et al., 2000).
Figure-3: Role of T cell and B cells in bone damage
Cytokines such as TNF-α is a major important factor of RA and mostly formed 
by  macrophages  in  the  synovial  membrane  and  at  the  cartilage–pannus  junction. 
Irregular  expression  of  TNF-α  is  the  major  cause  for  the  development  of  chronic 
arthritis. 
IL-6 also is a type of cytokine,  which plays  important role in acute arthritic 
conditions. An elevated level of this cytokine in synovial fluid is directly correlated 
with  degree  of  radiological  joint  damage  and  thus  it  promotes  the  formation  of 
osteoclasts. IL-6 is significantly produced by synovial fibroblasts and insignificantly by 
macrophages  (Wood  NC  et  al.,  1992).  It  helps  to  protect  the  cartilage  in  acute 
conditions and it encourages the bone formation in chronic condition. 
The  RA  synovial  tissues  contribute  to  cartilage  loss  by  two  principal 
mechanisms.  The  first  is  indirect  and  involves  the  effects  of  cytokines  and  other 
mediators  released  from  the  inflamed  synovium  that  produces  dysregulation  of 
chondrocyte function. TNF-α is a synovial factors that function in this manner.  The 
second mechanism by which RA synovial tissues adversely affect cartilage remodelling 
is direct and involves products, in addition to cytokines; produced by the RA synovium 
that have the capacity to degrade the articular cartilage matrix.
Figure-4: Enlarged view of arthritic joint
It has been reported that,  T cells play an important role in the pathogenesis of 
RA  (Kong  et  al., 1999).  The  generation  of  reactive  oxygen  species  occurs  when 
pathogens (bacteria) or immune complexes are ingested by phagocytic cells that form 
an oxidative burst to kill  the invading pathogens (Lotz,  2003). Free radical  such as 
reactive  oxygen  species  and reactive  nitrogen species  both  are free radicals,  which 
involved  in  stimulation  as  well  as  degeneration  of  synovium (Jaswal et  al.,  2003). 
Antigen-presenting  cells  (APC)  such  as  dendritic  cells,  macrophages, 
polymorphonuclear leucocytes, and T cell interrelate with plasma cell and B cell. This 
oxidative burst is mediated by the NADPH oxidase system and results in a marked 
increase in oxygen consumption and the production of superoxide (O2–•) and this is the 
first line of defense against pathogens. 
Superoxide plays a pivotal role in activation of the T-cell and T-cell mediated 
IL-2 and IFN-γ secretion (Smolen et al., 2007) which in turn increase the proliferation 
the T-cell. On the other hand it is also mediated by another strong reactive species H2O2 
generated from superoxide (Dröge, 2002) and H2O2 activates the transcription factor 
NF-kappa B (Dumont et al., 1999) which regulates the expression of several cytokine 
genes  including  IL-2  and  TNF-α  resulting  the  inflammation  of  joints  (Baeuerle  & 
Henkel, 1994).
Figure-5: Pathogenesis of Arthritis
It is reported that mostly synovial cells are derivative of T cell. When antigenic 
peptides binds to class II MHC molecules retrieve the binding of activated macrophage 
or oxidative burst to the T-cell receptor. As a result of which T-cell will get active and 
undergoes a final activation by binding of co stimulatory receptor CD-28 on T-cell and 
APC surface molecules (ligand) that  is CD-80 and CD-86 (Frauwirth & Thompson, 
2002). Strong activation of this co stimulatory receptor CD-28 leads to oxidative stress 
and its  helps significantly  decrease in intracellular glutathione redox state as well as 
increase the production of H2O2 causes further T-cell differention and proliferation (Los 
et al., 1995). B cell acts as antigen receptor due to presence of surface immunoglobin. 
Strong evidence reported that B cell makes a major contribution to the inflammatory 
process. T-H1 is a subset of T cell and it stimulates the activation of B-lymphocyte, 
fibroblast and osteoclast (Bombara et al., 1993). This co stimulation of B-cell by T-cell 
through cell surface molecule on B-cell leads to differentiate into plasma B-cell which 
secrets autoantibodies (Steiner & Smolen, 2006). 
The high level of RF is a major immunologic abnormality in RA which forms 
immune complexes that reinforce the production of proinflammatory cytokines such as 
TNF-α and IL-6 via complement and Fc-receptor activation (Debets  et al., 1988) and 
finally these proinflammatory cytokines can stimulate RANKL, which enhanced the 
osteoclast differentiation and bone erosion. Another strong ROS hydroxyl radical (OH.) 
is formed from H2O2 by Fenton reaction (Pillinger & Abramson, 1995) also peroxidize 
the polyunsaturated fatty acid (PUFA) of cell membrane of synovium which plays an 
important role in membrane destabilization.
Role of Oxidative Stress in RA
Oxidative  stress  occurs  when  there  is  an  imbalance  between  generation  of 
reactive oxygen species and inadequate antioxidant defense systems. Oxidative Stress 
(OS) is a general term used to describe the steady state level of oxidative damage in a 
cell, tissue, and disruption of macromolecular structure caused by the reactive oxygen 
species  (ROS)  (Davies,  2000).  Oxidative  stress  plays  an  important  role  in  the 
pathogenesis of RA. 
Oxidative  stress  constitutes  a  serious  pathophysiological  factor  for  a  wide 
variety of connective tissue disorders such as RA. In recent years, increasing attention 
has been given to the role of reactive oxygen metabolites in the pathogenesis of RA. 
Increased activity of free radicals, the unstable molecules associated with cell damage, 
is theorized to underlie the mucosal injury commonly seen in the various inflammatory 
diseases as RA (Lunec J et al., 1981). 
Figure-6: Sources of Cell damage
There  are  many different  sources  by which  the  reactive  oxygen  species  are 
generated.  ROS are the root cause of oxidative stress most of which come from the 
endogenous sources as by-products of normal and essential metabolic reactions, such as 
energy generation from mitochondria (Shouval & Elazar, 2007) or the detoxification 
reactions  involving the liver  cytochrome P-450 enzyme  system. Exogenous sources 
include exposure to cigarette smoke, environmental pollutants such as emission from 
automobiles and industries,  consumption of alcohol in excess, asbestos, exposure to 
ionizing radiation,  and bacterial,  fungal, or viral infections. ROS and other oxidants 
have been shown to be formed even in the normal physiological process (Abuja PM et  
al.,   2001). It is known that activated inflammatory cells lead to ROS production in RA 
a systemic autoimmune disease (Fox DA et al 2005). Increased reactive oxygen species 
(ROS) and other free radicals play an important role in the inflammatory process and 
contribute to tissue destruction can initiate lipid peroxidation and DNA damage leading 
to mutagenesis, carcinogenesis and cell death.
 Pathogenic mechanism of chronic inflammation is associated with increased 
the production of ROS and free radicals (superoxide anion and It hydrogen peroxide). 
Evidence  suggested  that  increased  oxidative  stress  as  well  as  defective  antioxidant 
status act  as mediators in the pathology of rheumatoid arthritis  (De Leo ME  et al., 
2002). The study showed raised levels of Malondialdehyde (MDA) and low levels of 
endogenous antioxidants in patients of rheumatoid arthritis. It has been reported that, 
the level of Plasma catalase is significantly lower in arthritic patients (Kamanli A et al., 
2004) and decrease the activity of glutathione reductase in the synovial fluids in-patient 
of rheumatoid arthritis (Bazzichi L et al., 2002).
The determinants  of  oxidative  stress are  regulated  by an individual's  unique 
hereditary  factors,  as  well  as  his/her  environment  and  characteristic  lifestyle. 
Unfortunately,  under  the  present  day  life-style  conditions  many  people  run  an 
abnormally high level of oxidative stress that could increase their probability of early 
incidence of decline in optimum body functions.
Cytoskeletal damage: Reactive oxygen species are also known to cooperate 
with cytoskeletal elements and interfere with mitochondrial aerobic phosphorylation; 
moreover, ATP depletion occurs (Buettner & Schafer, 2000).
Cartilage/  collagen  damage: Free  radical  enhanced  the  damage  of  cellular 
elements in cartilage directly and damage components of the extracellular matrix either 
directly or indirectly by upregulating mediators of matrix degradation (Henrotin YE et  
al., 2003). Reactive oxygen species Damage chondrocyte responses to growth factors 
and  relocation  to  sites  of  cartilage  injury;  Reactive  nitrogen  species  such  as  NO 
interfere with interactions between chondrocytes and the extracellular matrix (Clancy 
RM et al., 1997). NO may also increase chondrocyte apoptosis.
LYSOSOME 
                    Lysosomes discovered by the Belgian cytologist Christian de Duve in 1949 
are  membrane  bound  organelles  that  contain  several  digestive  enzymes.  Lysosome 
obtained the name from Greek meanings (lysis – destruction; soma - body). It is also 
known as suicidal bags by cell biologists due to their vital role in autolysis. Lysosome 
fuses with vacuole, releases the lysosomal enzymes in to vacuole, and thereby helps in 
digestion of contents of the vacuole. Lysosomal enzymes are mostly active at acidic pH 
of 4.5. It is reported that interior portion of the lysosome is far more acidic (4.8) than 
that of the cytosol (7.2). 
Figure-7: Basic Cellular Structures
Other functions include digesting foreign bacteria (or other forms of waste) that 
invade  a  cell  and  helping  repair  damage  to  the  plasma  membrane  by serving  as  a 
membrane patch, sealing the wound. In the past, lysosomes were thought to kill cells 
that were no longer wanted, such as those in the tails of tadpoles or in the web from the 
fingers of a 3- to 6-month-old fetus. While lysosomes digest some materials in this 
process, it is actually accomplished through programmed cell death, called apoptosis.
Functions 
They are used for digestion of macromolecules; from phagocytosis (ingestion of 
other dying cells or larger extracellular material), endocytosis (where receptor proteins 
are  recycled  from  the  cell  surface),  and  autophagy.  Autophagy  may  also  lead  to 
autophagic cell death, a form of programmed self-destruction, or autolysis, of the cell, 
which means that the cell is digesting itself.
Lysosomal enzymes
Lysosomal enzymes are synthesized in the cytosol and endoplasmic reticulum 
and it receives a tag of mannose-6- phosphate that helps the enzymes to target itself to 
the lysosomes. Few of them are explained below.
Acid  phosphatase:  Acid  phosphatase  comes  under  the  category  of  acid 
hydrolases and it consists of subunits that polymerizes at an acidic pH, thus it shows 
high  enzymatic  activity  in  specific  granules  of  eosinophils  (Bass  DA  et  al.,  1981, 
Weller  PF  et  al 1983).  It  is  mainly  involved  in  the  catabolism  of  glycoprotein, 
glycolipid, and glycosaminoglycans.
Cathepsin-D:  Cathepsin-D  is  an  aspartic  endo-protease  and  it  is  widely 
distributed in lysosome (Barret AJ  et al., 1970). Cathepsin-D plays a pivotal role in 
degradation of protein-degrading enzyme and protein in lysosome at acidic pH. Reports 
suggested that cathepsin-D also participate in activation of biologically active proteins 
in pre lysosomal compartments of specialized cells (Diment S et al., 1989). Cathepsin-
D is synthesized on the rough endoplasmic reticulum (RER) as a pre-pro-enzyme that 
undergoes several proteolytic cleavages during biosynthesis to produce the mature form 
(Richo G et al., 1994).
β Glucuronidase:  β Glucuronidase is mostly localized in lysosome and some 
amount  is  present  in  the  endoplasmic  reticulum.  It  catalyses  the  hydrolysis  of 
glucuronides and it shows some idiosyncrasy function. It half-life is very short and it 
clears itself from the plasma by the liver Kupffer cells. β Glucuronidase is shown to be 
a sensitive marker of lysosomal integrity (Ravichandran LV et al., 1990).
N - Acetylglucosaminidase (NAG): NAG, a lysosomal enzyme ubiquitous to 
cell and it is normally present in the cells as well as human plasma. It has been report 
that elevated levels of NAG found in several inflammatory condition and its leads to 
alter  the  metabolism  of  different  connective  tissue  constituents  such  as  cartilage, 
glycoprotein, and glyaminoglycans(Price RG et al.,1972).
Arthritis Models: Several types of models are available for arthritis in rats. Some 
of the following models as mention below. 
Pristane-induced  arthritis  in  rat: It  is  also  a  type  of  animal  model  for 
rheumatoid arthritis induced with well-defined synthetic immunological adjuvant oil, 
pristine. Pristane induced arthritis developed after two week with a single intradermal 
injection of 150 micro liters of pristine , as well as the rat suffered sever and chronic 
arthritis .The inflammation was restricted to the joint sand involved  pannus formation, 
major  histocompatibility  complex  (MHC  )  Class  II  expression  and  T-lymphocyte 
infiltration (Crofford & Wilder, 1997).
Collagen type II induced arthritic: It is an extensively studied animal model 
of RA. It shows various pathological and an immunological features of human RA. 
CIA  is  primarily  an  autoimmune  disease  of  joints,  requiring  both  T  and  B  cell 
immunity to autologous type II collagen (CII) for appearance of disease (Wilder et al., 
1999). 
Adjuvant induced arthritis: This type of arthritis induced by an intradermal 
injection,  of heat  killed Mycobacterium tuberculosis  in  IFA at  the base of  the tail, 
results  in destructive arthritis  within 14 days  in susceptible  DA or LEW inbred rat 
strains.  AIA can also be induced with cell  walls from other bacterial  types  in IFA, 
although  the  arthritogenicity  varies.  Its  shows  elevated  level  of  cytokines  due  to 
increase the synthesis of tumor necrosis factor a (TNF-α), interleukin 1 (IL-1) and IL-6 
is detected as early as day four after adjuvant injection. Granulocytes and auto reactive 
CD41 cells play major roles in the disease. Humoral immune mechanisms appear not to 
contribute to the disease process. This unique rat disease model represents a systemic 
process that involves not only the joints but also the gastrointestinal and genitourinary 
tracts, the skin and the eyes (Wilder et al., 1999).
Arthritis  Induced by Systemic Injection of Streptococcol  Cell  Wall: It  is 
another  type  of  rat  model,  which  includes  various  form  of  bacterial  cell  wall 
peptidoglycan-polysaccharide induced arthritis in female Lewis rats. The Streptococcal 
cell wall is one of the most reliable and best characterized experimental models of RA. 
A  single  intraperitoneal  injection  of  the  Streptococcal  cell  wall  component 
peptidoglycan-polysaccharide (PGPS), suspended in an aqueous phase will induce a 
chronic, severe, erosive arthritis in female Lewis rats (Wilder, 1988).
Proteoglycan-induced progressive polyarthritis in rat: As reported by Glant 
et al (1987, 1992), Poole (1989) Mikecz et al (1987, 1990), that proteoglycan-induced 
progressive  arthritis  and  spondylitis  in  BALB/C  mice.  This  model  has  few 
characteristics such as presence of rheumatoid factor and the deposition of immune 
complexes  similar  to  human  rheumatoid  arthritis  and  ankylosing  spondylitis  as 
indicated  by  clinical  assessments,  immunological  parameters,  and  histopathological 
studies of diarthrodial joints and spine (Crofford & Wilder, 1997).
Papaya  Latex  –induced  Arthritis: Papaya  latex  induced  inflammation  has 
known  to  be  mediated  through  prostaglandins.  They  are  also  used  extensively  to 
evaluate potential of new therapeutic agents for anti-inflammatory activity of the slow- 
reacting anti-rheumatic drugs (Wilder et al., 1999). For this 0.1 ml of 0.25% solution of 
papaya  latex (prepared in 0.05 M sodium acetate buffer, ph 4.5 containing ( 0.01% 
thymol ) is injected into rat hind paw. The method is sensitive for appraising NSAIDs 
like  aspirin,  ibuprofen  and steroidal  anti-inflammatory  drugs,  which  do  not,  shows 
appreciable activity in adjuvant-induced arthritis and other model of inflammation
Complete Freund’s Adjuvant (CFA)
CFA  is  a  water-in-oil  emulsion,  is  composed  of  dried,  heat  killed 
mycobacterium tuberculosis,  and  is  used  as  booster  of  immune system.  CFA is  an 
effective  means  of  potentiating  cellular  and  humoral  antibody  response  to  injected 
immunogens  CFA  can  produce  delayed  hypersensitivity  of  extreme  severity  to  a 
foreign antigen and at times sensitize an animal to its own tissue (Freund, Thompson & 
Lipton,  I955)  (auto-immunity).  Intradermal  injection  of  CFA causes  several  painful 
reactions and leads to tissue damage, skin ulceration, and pulmonary lipid embolism. 
Thus, the subcutaneous and intraperitoneal routes are always preferred. 
Figure-8: Mechanism of CFA in Arthritis
The adjuvant is known to stimulate production of tumor necrosis factor, which 
is  thought  to  kill  the  T-cells  responsible  for  the  autoimmune  destruction  of  the 
pancreatic Beta cells. Adjuvant activity is a result of sustained release of antigen from 
the  oily  deposit  and  stimulation  of  a  local  innate  immune  response  resulting  in 
enhanced adaptive immunity.  An essential  component of this response is an intense 
inflammatory  reaction  at  the  site  of  antigen  deposition  resulting  from an  influx  of 
leukocytes and their interaction with antigen. The use of CFA is an important biologic 
resource for investigators, which should be used responsibly and with care to avoid or 
minimize the adverse effects of excessive inflammation.
Statistical Data
More than 30 millions Americans suffer symptoms of one form or another of 
rheumatic disease. These are inflammatory or degenerative disorders that mainly affect 
the musculoskeletal system that is such structures as joints, muscles, ligaments, tendon, 
and bursae. This disease, which afflicts more than 5 million Americans, is characterized 
by chronic inflammation of the synovial membranes, a layer of loose connective tissue 
that lines joints  and secretes a lubricating fluid. At least  20 million people in India 
suffer arthritis.  The market for pain killer for arthritic pain is approximately Rs.500 
crore in India. This means there are an astonishing number people who suffer from 
musculo-skeletal pain.
Drugs therapy
Conventional  medicine  treats  arthritis  with  anti  inflammatory  drugs  (most 
commonly aspirin) and physiotherapy.  In severe cases of rheumatoid arthritis,  more 
potent anti-inflammatory drugs are used; nonsteroidal anti- inflammatory drugs such as 
Indomethacine,  cortisone-like drugs, antimalarials gold salts,  penicillamine and even 
experimental  cytotoxic  drugs.  Around  the  world  know  of  many  plants  with  anti-
inflammation and anti-arthriti properties. Unfortunately chemical identification of the 
anti-inflammatory  components  are  usually  given  much  more  attention  than 
thantherapeutic use of the herbs. This is because the plants are viewed as sources of 
potentially  valuable  drugs  rather  than  having  inherent  value  in  themselves.  Some 
examples  of herbal  drugs are  Menyanthest  trifoliate,  Urtice dioica,  Harpagophytum 
procumbens, Chelidonium majus, Commiphora mukkul, Ficus elastica, Lonchocarpus 
cyanescences, and Scutellaria baicalensis.
Natural treatments for Arthritis
Though several studies involving drugs have been performed, natural herbs and 
plants  still  play  a  vital  role  in  the  treatment  of  several  categories  of  diseases.  The 
research of natural medicinal sources provides immense positive results and the main 
reason behind its usage is its property of not showing any side effects. Some of them 
have been mentioned.
Turmeric:  -  Turmeric  is  a  wonderful  anti-inflammatory  that  can really  ease 
joints' swelling, which is a major part of arthritis and will help to lessen the pain of 
arthritis substantially. 
Cayenne pepper: - Cayenne pepper has similar positive effects in the treatment 
of arthritis. These effects have been endorsed by clinical trials.
Ginger: - Ginger contains Zingibain and other phytochemicals, which reduce 
swelling, which can be very beneficial to arthritis sufferers. Long-term, Ginger is great 
for protecting the body from free radicals, which do much damage including speeding 
up the damage of arthritis and causing cancer.
Pineapple: -Pineapple significantly reduces the inflammation of Arthritis flare-
ups. However, Pineapple is most effective when combined with other herbal treatments 
in tablet form as most of its goodness is contained in the stem.
Celery: - Celery, especially the seeds has excellent anti-inflammatory properties 
that ease stiff joints, which are a main characteristic of arthritis.  The seeds work by 
helping  to  strip  out  the  solid,  which  induces  a  diuretic  effect  and  helps,  remove 
deposits, which collect in the joints of arthritis sufferers. The seeds can be taken in tea 
or tincture form.
Ginkgo:  - Ginkgo increases blood circulation,  which helps to ease pain, and 
swelling in arthritic joints. Comfrey is a great anti-inflammatory boost to the immune 
system that will stimulate healing in damaged joints.
Few others include -
Arthcare  Capsules  /  Oil: Arthcare  is  an  herbal  preparation,  which  is  anti-
arthritic and anti-inflammatory and helps in comfortable movement and strengthening 
of bones, skeletal system, and muscular system by faster penetration into the tissues of 
the body. It could also be relied upon for, rheumatic and joint pains. It is also a strong 
antioxidant  and  increases  energy  levels.  Arthcare  capsules  are  an  unique  blend  of 
various  herbs  and  are  proven  safe  and  effective  for  those  suffering  from acute  or 
chronic Rheumatoid Arthritis.
Shallaki (Boswella Serrata): - This herb, also known as Boswella, is an herb 
found in India and has been used by Ayurvedic physicians over the years for treatment 
of  Rheumatoid  arthritis.  Extract  of  Boswella  reduced  pain,  swelling,  and  morning 
stiffness when administered to those suffering from Rheumatoid Arthritis. Due to the 
high  anti-inflammatory  property  of  this  herb,  it  inhibits  substances  causing 
inflammation, speeds up formation of cartilage, and increases blood supply. 
Ashwagandha  (Withania  Somniferum):  - Ashwagandha  root  is  a  holistic 
medicine of Indian origin, belonging to the potato family, which has been used to treat 
Rheumatoid Arthritis. Because of its high anti-inflammatory property, it is also called 
“India ginseng”. It rejuvenates and nourishes body tissues and helps in physical fitness. 
Tripterygium wilfodii Hook F (TWH); - TWH, a herbal plant growing mainly 
in  South China,  was described in ancient  Chinese medical  texts  and has been used 
widely in China for treatment of joint pain. Patients receiving TWH showed significant 
improvement  in  all  parameters  compared  with  placebo:  tenderness  score,  swelling 
count, morning stiffness, and grip strength.
RA-1  (standardized  Ayurvedic  formulation):  -  RA-1  is  a  standardized 
formulation  prepared  from  purified  plant  extracts  of  Withania  somnifera 
(ashwagandha), Boswellia serrata (gugulla), Zingiber officinale (adrak or ginger) and 
Circuma longa (haldi or circumin).
TAXONOMY AND ETHNO MEDICINE OF
Gaultheria fragrantissima Wall.
SYNONYM:
Gaultheria forrestii Diels
FAMILY: 
The species belongs to family “Ericaceae”.
SUBFAMILY: 
Vaccinioideae
TRIBE: 
Gaultherieae
GEOGRAPHICAL DISTRIBUTION: 
INDIA : This plant is found in the Nilgiris, Travancore 
(Above  5,000  ft.),  North  Eastern  Himalayas 
(Khasi Hills).
ASIA Temperate zone : China
ASIA Tropical zone : From Nepal to Bhutan, 6,000-8,000 ft., 
Sri Lanka, Myanmar, Vietnam, and Malaysia.
VERNACULAR NAMES: 
HIND: Gandapuro
TAM:  Kolakkai
KAN : Moolai
SANS: Caramapatra, Nilaphala, Swetapuspa, Talipatra, Hemantaharita
ENG: Indian Wintergreen
JAVA: Gandapuro
NEPAL: Machino
SINHALESE: Welkapuru
DESCRIPTION
                 It is an evergreen shrub, usually small, low and much branched, bark orange 
brown, twig pink, young parts glabrous.
                 LEAVES: Leaves are numerous, persistent, 3.8-6.3 cm., on short stourt 
petioles, oblong-oval or oblong-lanceolate, rounded at base, obtuse, blunty, apiculate, 
serrate, glabrous, stiff and coriaceous, venation reticulate, conspicuous, bright green, 
rather glaucous, and with scattered sunk glands beneath.
Figure-9: Dried leaves of Gaultheria fragrantissima Wall.
MEDICINAL USES
            Volatile oil (methyl salicylate) distilled from leaves and shoots traditionally 
used in acute rheumatism,  sciatic  and neuralgia.  The oil  is  aromatic,  stimulant,  and 
carminative. The oil is also applied as externally in liniments, or in form of suitable 
ointment. It has powerful antiseptic properties. 
Oil  of  wintergreen  and  methyl  salicylate  is  moderately  potent  vermicides 
against hookworms, which are expelled dead and in a flaccid state; but they are without 
effect against roundworm.
CHEMICAL CONSTITUENTS OF LEAVES
Beta-Sitosterol
Quercetin 3 galactoside
Ursolic acid
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AIM AND SCOPE OF STUDY
Rheumatoid  arthritis  (RA)  is  a  chronic  autoimmune  disorder  with  swelling, 
pain, stiffness, deformity, and cartilage destruction. Rheumatoid arthritis affects 1% of 
the worldwide general population and it is 2 to 3 times more common in women than in 
men. However, the cause of RA, still  remains unknown, it  is accepted that reactive 
oxygen  species  has  been  proved  to  play  the  major  role  in  pathogenesis  of  RA. 
Lysosomes are membrane bound organelles that contain digestive enzymes, which are 
stored in the sub cellular organelles termed lysosomal granules. It has been proved that 
Lysosomal enzymes play an important role in adjuvant induced arthritis by altering the 
metabolism of glycoprotein and glyaminoglycans. It has been proved that CFA induced 
arthritis significantly improve the level of inflammation and increases the extracellular 
activities of lysosomal enzymes.  This eventually leads to membrane damage, which 
finally leads to cartilage destruction and bone resorption.
         Complete  Freunds  Adjuvant  (CFA)  is  composed  of  dried,  heat  killed 
mycobacterium tuberculosis is used as booster of immune system. Freund's complete 
adjuvant (FCA) can produce delayed hypersensitivity of extreme severity to a foreign 
antigen and at times sensitize an animal to its own tissue. Several instances have been 
reported where intradermal injection of CFA causes several painful reactions and leads 
to tissue damage, skin ulceration, and pulmonary lipid embolism. This eventually leads 
to rheumatoid arthritis and thus it is used as a model of chronic inflammation in rats for 
the pharmacological and pathophysiological control of inflammatory responses. Strong 
relation  between the  efficiency of  therapeutic  agents  in  this  model  and  rheumatoid 
arthritis  in humans quotes for its worldwide utilization. Several evidences suggested 
that  arthritis  induced  by  CFA  leads  to  significant  increase  in  the  level  of  pro-
inflammatory  cytokines  in  the  synovial  fluid.  These  are  mediated  by  primarily  by 
activation of “effectors cells” macrophages and connective tissue (fibroblast). Previous 
reports proved that herbal therapies provide an approach in the treatment of various 
ailments including arthritis.
Gaultheria fragrantissima Wall (GF) (family-Ericaceae) commonly known as 
Indian wintergreen oil, is cultivated on high altitude. It is an evergreen shrub, cultivated 
for medicinal  uses against  acute  rheumatism,  sciatic  and intercostals  neuralgia.  The 
leaves of plant  Gaultheria fragrantissima Wall, has been considered most active for 
therapeutic purpose. Several reports suggest that the plant  Gaultheria fragrantissima 
Wall possess antidiabetic, anticancer, diuretic, hypothermic, analgesic and antiepileptic 
activities.  The  major  constituents  present  are  beta-sitosterol,  quercetin-3-galactoside 
and  ursolic  acid.  Reports  suggest  that  beta-sitosterol  posse’s  antioxidant  and  anti-
inflammatory activity in oedema. It also shows potential activity against rheumatoid 
arthritis  in rats. Moreover, it  has been well  documented that quercetin-3-galactoside 
(polyphenolic  flavonoid),  and ursolic  acid (pentacyclic  triterpenoid)  scavamges  free 
radicals. Cumulative studies prove that ursolic acid is effective in rheumatoid arthritis 
as  hepatoprotective  and  cardioprotective  activities.  In  our  previous  published  data 
suggest  the  antioxidant  potential  of  Gaultheria  fragrantissima  Wall against  CFA 
induced arthritis in rat liver. In current study the Efficacy of Gaultheria fragrantissima 
Wall. on lysosomal destabilization and inflammation by CFA induced arthritis in rat 
liver.
PLAN OF WORK
1. Collection, identification and authentication of Gaultheria fragrantissima Wall. 
Leaf
2. Extraction of dried plant material
 Hot continuous  percolation  using  Soxhlet  apparatus 
by ethanol (70% v/v) as solvent.
3. Estimation of Lysosomal Enzymes
 β-D-glucuronidase
 Acid phosphatase
 β-D-N-acetyl glucosaminidase
 Cathepsin D
4. Estimation of Cytokine Levels
 Estimation of  TNF-α
 Estimation of IL-6
5. Estimation of Glycoprotein
 Hexose
 Hexosamine
 Sialic acid
6. Histopathological studies
7. X- ray study
MATERIALS AND METHODS
COLLECTION AND AUTHENTIFICATION OF PLANT MATERIAL
Gaultheria fragrantissima  Wall leaf was collected from Survey of Medicinal 
Plants & Collection Unit, Ooty, Tamilnadu, India and authenticated (voucher no of the 
specimen:  PARC/2008/129)  by Plant  Anatomy Research  Centre  (PARC) Medicinal 
plant Research Unit, Chennai, India.
Extraction procedure:
The collected sample of Gaultheria fragrantissima  Wall leaf was shade dried 
for 1-2 weeks and grind to make a coarse powdered form. The coarsely powder was 
subjected to hot continuous percolation using ethanol (70% v/v) as solvent. The extract 
was concentrated under vacuum, and then dried in a vacuum desiccators (yield 9.3% w/
w), and stored in an air- tight containers for further use.
BIOCHEMICAL ESTIMATIONS
Animals:
The study was performed on male albino rats of Wistar strain (average weight 
of  150-180 g),  obtained  from Experimental  Animal  Care  Centre,  Vel’s  College  of 
Pharmacy,  Chennai,  India.  The experimental  protocol  was approved by Institutional 
Animal  Ethical  Committee  (IAEC)  of  Committee  for  the  Purpose  of  Control  and 
Supervision of Experiments on Animals (CPCSEA), Government of India, Ministry of 
Culture, Chennai. The animals were housed in standard laboratory conditions 12 ± 1 h 
day and night rhythm during the experimental period and they were given food and 
water supplied by Hindustan Lever Ltd.,  Mumbai,  India under the trade name Gold 
Mohur rat feed and water ad libitum.
Experimental Protocol: 
Animals were divided into four groups of six animals in each group as follows:
Group I: Control rats received water and food. 
Group II: Arthritic rats served as induced [arthritic syndrome was induced by 
single subcutaneous injection of 0.1 mL of CFA (10 mg of heat killed Mycobacterium 
tuberculosis mL-1  of paraffin oil) into the plantar surface of right hind paw, exactly on 
the first day of the experimental period].
Group III: Control rats administered with extract of GF (200 mg kg-1 days-1) 
for 28 days.
Group IV: Arthritic rats treated with GF (200 mg kg-1day-1) orally for 14 days 
(from day 14 to day 28). 
After  the  experimental  period  all,  the  animals  were  anesthetized  and 
decapitated.  Liver  tissues  were  immediately  excised  and  rinsed  in  ice-cold 
physiological saline. The tissues were homogenized in 0.01 M Tris-HCL buffer, (pH 
7.4) and aliquots of this homogenate were used for the assay. Blood was collected and 
serum was separated for analysis of biochemical parameters.
Biochemical Investigation procedure
Isolation of lysosome
Lysosomal fraction was isolated by the method of Wattiaux (1977). 
 Reagents
1. Sucrose solution :     0.25 M
2. Potassium chloride :     1.15%
 Procedure
Fresh  liver  tissue  was  homogenised  in  0.25  M  sucrose  solution.  The 
homogenate was filtered and centrifuged at 3,000 × g for 10 minutes in a refrigerated 
Beckman  J2-21  centrifuge.  The  pellet  was  removed  and  re-homogenised  and 
resuspended  as  before.  The  supernatants  were  combined  and  centrifuged  again  at 
15,000 × g for 20 minutes. The lysosomal pellet obtained was suspended in 1.15% KCl, 
homogenised and used for the estimation of enzymes.
Assay of β-D-glucuronidase 
The activity of β-D-glucuronidase was determined by the method of Kawai 
and Anno (1971).
 Reagents
1. 0.5 M NaOH
2. Sodium acetate buffer : 0.1 M, pH 5.0
3. p-nitrophenyl β-D-glucuronide : 2 mM
4. Glycine - NaOH buffer : 0.2 M, pH 11.7 containing 2 M 
SDS
 Procedure
Known aliquot  (0.2  ml)  of  the  enzyme  source  was  added  to  0.5  ml  of 
incubation  buffer  containing  2 mM substrate  (final  concentration)  and incubated  at 
37°C for 2 hours. The substrate p-nitrophenyl β-D-glucuronide was dissolved in 0.1M 
acetate buffer. At the end of the incubation period, the reaction was stopped by the 
addition of 4.0 ml of 0.2 M glycine-NaOH buffer and the contents were centrifuged. To 
the aliquots of supernatants, 0.5 M NaOH was added and the absorbance was measured 
at 410 nm in a Shimadzu UV spectrophotometer.
The enzyme activity was expressed as µmoles of p-nitrophenol liberated/mg 
protein.
Assay of Acid phosphatase (ACP)
Acid phosphatase was assayed by the method of King (1965a).
Reagents
1. Acetate buffer : 0.1 M, pH 4.8
2. DPP : 0.01 M 
3. Folin’s phenol reagent : Commercial reagent, 1:2 dilution
4. Sodium carbonate : 15% solution
5. Standard phenol : 100  mg  of  recrystallised  phenol  in 
100 ml of water. 
6. Working standard : 100 µg of phenol/ml was prepared by 
proper dilution.
Procedure
The incubation mixture of final volume 3.0 ml containing 1.5 ml of 
buffer,  1.0  ml  of  substrate  and required  amount  of  the  enzyme source  were 
incubated at 37°C for 15 minutes. The reaction was arrested by the addition of 
1.0 ml of Folin’s phenol reagent. To the control tubes, enzyme was added after 
arresting the reaction. The contents were centrifuged and 1.0 ml of 15% sodium 
carbonate  was  added  to  the  supernatant.  The  mixture  was  incubated  for  15 
minutes at 37°C and the colour developed was read at 640 nm in a Shimadzu UV 
spectrophotometer.
The enzyme activity was expressed as IU/l for serum and µmoles of 
phenol liberated/h/mg protein for tissue.
Assay of β-D-N-acetyl glucosaminidase
The activity of β-D-N-acetyl glucosaminidase was assayed by the procedure 
of Moore and Morris (1982).
 Reagents
1. Glycine - NaOH buffer : 0.2 M, pH 11.7 containing 2 M SDS
2. Citrate buffer : 0.1 M, pH 4.5
3. Standard : 6 mM p-nitrophenol 
4. Substrate : 2 mM p-nitrophenyl β-D-N-acetyl 
glucosaminide  
 Procedure
Known aliquots  (0.2  ml)  of  the  enzyme  source  was added to  0.5  ml  of 
incubation  buffer  containing  2 mM substrate  (final  concentration)  and incubated  at 
37°C for 2 hours. At the end of the incubation period, the reaction was stopped by the 
addition of 4.0 ml of glycine-NaOH buffer and the contents were centrifuged. To the 
aliquots of supernatants, 0.5 M NaOH was added and the absorbance was measured at 
410 nm in a Shimadzu UV spectrophotometer.
The enzyme activity was expressed as µmoles of p-nitrophenol liberated/h/
mg protein.
Assay of Cathepsin D
Cathepsin  D  activity  was  determined  by  the  method  of  Sapolsky  et  al. 
(1973).
 Reagents
1. NaOH : 1 N
2. TCA : 10%
3. Substrate : 1.5%  haemoglobin  in  0.1  M  acetate 
buffer, pH 3.0
4. Folin’s phenol reagent : Commercial reagent, 1:2 dilution
 Procedure
Known aliquots (0.2 ml) of the enzyme source was incubated with 1.5% 
haemoglobin for 2 hours. The enzyme activity was arrested by the addition of 10% 
TCA and the liberated TCA soluble products were filtered and neutralized with 1 N 
NaOH. The tyrosine content of the filtrate was determined using Folin’s phenol reagent 
essentially  employing  the procedure of  Lowry  et  al.  (1951)  as described.  The blue 
colour developed was read at 660 nm in a Shimadzu UV spectrophotometer.
The enzyme activity was expressed as µmoles of tyrosine liberated/ h/100 
mg protein.
Assay Of Tumour Necrosis Factor - Α (TNF - α)
The level of TNF-α was measured by using enzyme linked immunosorbent 
assay as described earlier in section using mouse monoclonal antibody against rat TNF-
α (1:5000 dilution) and Goat-ant mouse IgG-HRP conjugate.
The level  of  TNF-α was expressed  as  ng/mg protein  using a  calibration 
curve obtained from standard TNF-α.
Assay of Interleukin – 6; (IL-6)
The level of IL-6 was measured by using enzyme linked immunosorbent 
assay as described earlier using mouse monoclonal antibody against rat IL-6 (1:5000 
dilution) and Goat-antimouse IgG-HRP conjugate.
The level of IL-6 was expressed as ng/mg protein using a calibration curve 
obtained from standard IL-6.
ANALYSIS OF GLYCOPROTEIN COMPONENTS
Estimation of Hexose
Hexose was estimated by the method of Neibes (1972).
Reagents
1. Orcinol-sulphuric acid reagent :
Reagent A : Sulphuric acid-water mixture (3:2 v/v)
Reagent B : 1.6 g of orcinol in 100 ml of water
Reagents A and B were mixed in the ratio of 15:2 (v/v)
2. Hydrochloric acid :  4 N
3. Sodium hydroxide :  4 N
4. Standard hexose : Equal  quantities  (10  mg/100  ml)  of 
galactose and mannose were dissolved in water to give a concentration 
of 100 µg/ml.
Procedure
0.5 ml of the neutralized sample was made up to 1 ml with water and 2 ml 
of orcinol-sulphuric  acid reagent  was added to the tubes in  ice-cold condition very 
slowly.  The  tubes  were  read  at  540  nm  after  20  minutes  in  a  Shimadzu  UV 
spectrophotometer.  Standard  hexose  in  the  range  of  20-100 µg/ml  and  blank  were 
treated in the same manner.
The values were expressed as mg/100mg of dry defatted tissue.
Esitmation of Hexosamine
Hexosamine was estimated by the method of Wagner (1979).
 Reagents
1. Acetyl acetone reagent: 3.5% acetyl acetone in 1 N trisodium phosphate 
and 0.5 N potassium tetraborate were mixed in the ratio of 98:2 (v/v).
2. Ehrlich’s  reagent:  320  mg  of  p-dimethyl  aminobenzaldehyde  was 
dissolved in 21 ml of isopropanol and 3 ml of concentrated hydrochloric 
acid.
1. Standard hexosamine: Galactosamine hydrochloride solution containing 
10 mg/100 ml was prepared.
2. Hydrochloric acid   :  4 N
5. Sodium hydroxide   :  4 N
 Procedure
To 0.8 ml of the neutralized sample, 0.6 ml of acetyl acetone reagent was 
added. Blank contained 0.8 ml of distilled water. The tubes were heated in a boiling 
water bath for 30 minutes. The tubes were cooled and then 2 ml of Ehrlich’s reagent 
was  added.  The  colour  developed  was  read  at540  nm  in  a  Shimadzu  UV 
spectrophotometer.  Standard  galactosamine  in  the  range  of  10-40  µg,  were  also 
processed in the same manner.
The values were expressed as mg/g of dry defatted tissue.
Estimation of Sialic acid
Sialic acid was estimated by the method of Warren (1959).
Reagents
1. Sodium meta periodate : 0.2 M in 9 M phosphoric acid 
2. Sodium arsenite : 10% in 0.5 M sodium sulphate in 0.1 N 
sulphuric acid
3. Thiobarbituric acid : 0.6% in 0.5 M sodium sulphate
4. Acidified butanol : 100  ml  of  butanol  containing  5  ml  of 
concentrated HCl
5. Standard : N-acetyl  neuraminic  acid  solution 
containing 100 µg/ml in distilled water.
 Procedure
To 0.2 ml of the hydrolysed sample, 0.2 ml Sodium meta periodate reagent 
was added and kept at 37°C for 20 minutes. Then 0.2 ml of sodium arsenite was added 
and shaken well. After adding 3 ml of thiobarbituric acid, the tubes were heated in a 
boiling water bath for 15 minutes. The tubes were cooled and 5 ml of acidified butanol 
was added. The absorbance of the pink butanolic phase after centrifugation was read at 
540  nm  in  a  Shimadzu  UV  spectrophotometer.  Standards  and  blank  were  also 
processed in the same manner.
The values were expressed as mg/g of dry defatted tissue.
HISTOPATHOLOGICAL STUDIES
The ipsilateral (injected) proximal interphalangeal joints were excised, fixed in 
10% neutral buffered formalin, decalcified in 5% nitric acid and processed paraffin wax 
embedding. Sections were cut at 3 µm thickness, flattened and adhered to the slides. 
They  were  stained  with  hematoxylin-eosin  and  viewed  under  light  microscope  for 
histopathological changes.
X-RAY STUDIES
            Before sacrificing the animals, X-ray were taken at the joints of hind paw of 
animals for evaluating the bone damage. 
STATISTICAL ANALYSIS
All the grouped data were statistically evaluated with Statistical Package for 
Social Sciences (SPSS), Version 7.5.  Hypothesis testing methods included one way 
analysis of variance (ANOVA) followed by least significant difference (LSD) test. A 
‘P’ value of less than 0.05 was considered to indicate statistical significance. All the 
results were expressed as mean + S.D. for six animals in each group.
RESULTS
Table-1 represents Effect of CFA and GF on body and tibia weight in control 
and  experimental  animals,  in  CFA  induced  arthritis  (Group-II)  the  weight  are 
significantly reduced (p < 0.05) in comparison to control (Group I). Administration of 
GF extract  (Group IV) increased the weight significantly (p < 0.05) near to normal 
level as control (Group I). GF extract (Group III) treated alone shows normal as control 
(Group I).
Table-2 represents the effect of CFA and GF on Lysosomal enzymes in liver of 
control  and  experimental  animals.  The levels  of  Lysosomal  enzymes  such  as  N-
acetylglucosaminidase  (NAG),  betaglucuronidase,  acidphosphatase,  and  cathepsin-D 
were significantly (p < 0.05) increased in Group-II in comparison to Group-I in liver. 
After treatment with GF, these lysosomal enzyme levels were reduced near to normalcy 
comparing with Group-II. GF extract treated alone (Group III) shows normal as control 
(Group I).
Table-3  represents  the  Effect  of  CFA  and  GF  on  glycoproteins  in  liver  of 
control and experimental animals. The marked increase in levels of glycoproteins such 
as Hexose,  Hexosamine,  and Sialic  acid,  significantly (p < 0.05) in Group-II (CFA 
induced) rat was compared to Group-I, while Group-IV (GF extract) shows reduced 
levels of these enzymes compared to Group-II. GF extract treated alone (Group III) 
shows normal as control (Group I).
Figures-10 and figure-11 represents the effect of CFA and GF on TNF-α and IL-6 
level  in  serum  of  control  and  experimental  animals.  The  levels  of  pro-inflammatory 
cytokines such as TNF-α and IL-6 are significantly (p < 0.05) increased in Group-II 
when compared  to  Group-I  and  it  is  significantly  (p  < 0.05)  restored  in  Group-IV 
compared to Group-II. GF extract treated alone (Group III) shows normal as control 
(Group I).
Plate I shows Histopathological examinations of proximal interphalangeal joints 
in control and experimental animals. In Figure-12 (control) showing normal articular 
surface with joint space compared to Figure-13 (CFA induced) where joint showing 
damaged articular cartilage and space with adjacent area of inflammatory granulation 
tissue. Figure-14 (GF extract 200mg/kg/bw) showing that damage is restrained but the 
inflammatory granulation tissue is present less than Figure-13 (CFA induced).
Plate  II  shows  X-  ray  study of  rat  foot  region  in control  and  experimental 
groups. The pictures shows marginal erosion in the joint and swelling in CFA induced 
arthritic rats (Group II) in comparison with control (Group I). In GF treated arthritic 
rats, (Group III) these changes were normalized which indicates its protective effect. 
GF extract treated alone (Group III) shows normal as control (Group I).
DISCUSSION
Rheumatoid arthritis has been proved as an inflammatory responses mediated 
autoimmune disease,(Levinson  et  al.,  1994), characterized by leukocyte infiltration, 
swelling,  pain,  stiffness,  destructive  damage  of  joint  tissues,  as  well  as  hyper 
proliferation of the synovial  cells  (Page c et al 2002, Koch AE et al 1998) and the 
initiation  of  a  chronic  inflammatory  state  that  involves  overproduction  of  pro-
inflammatory cytokines (R, Fleischmann et al 2004,J.M Dayer et al 2003). Mounting 
evidences  proved  that  CFA induced  RA may  generate  enormous  free  radicals  and 
decrease in antioxidant scavenger leads to oxidative stress (Bandyopadhyay U, et al, 
1999).  Several  evidences  proved  that  free  radicals  and  their  derivatives  play  an 
important role in pathogenesis of the autoimmune disorders (Blake DR, et al 1981). 
The hydroxyl radicals formed by the Fenton reaction of ferrous ions and H2O2, leads to 
iron deposition produce deterous effect to proteins, DNA, and the membrane lipids. 
These  radicals  are  also  involved in  autoantibody production,  which  inactivates  α-1 
antiproteinases,  conformations,  antigenicity,  and destruction of synovial  antioxidants 
(Gutteridge J.M.C.et al, 1986, G.Tsuji et al, 2006). It has been report that antioxidants 
play an important  role  in  free radical  scavenging activity  and our  previous  studied 
proved that Gaultheria Fragrantissima Wall (Ericaceae) possesses antioxidant activity 
against CFA induced arthritis in rats (Shanmugarajan et al 2008). However, the current 
study demonstrated the anti-inflammatory and lysosomal membrane stabilizing effect 
of GF against CFA induced arthritis.
            Oxygen free radicals (OFRs) are implicated as mediators of hepatic injury in 
rheumatoid  arthritis  shown by our  previous  study (Rainsford et  al,  1982).  Reactive 
oxygen  species  react  with  membrane  lipids  causing  lipid  peroxidation 
(  Heliovaara  et  al,  1994)and subsequent  leads  to  membrane  destruction  (Marnett  et 
al,1999).  Lysosomes are  membrane bound structures  that  contain several  hydrolytic 
enzymes that are involved in the digestion of endogenous and exogenous compounds 
(R.T.Narendhirakannan et al, 2006,).  Cumulative studies reported that these enzymes 
are important mediators of hepatic injury and its release into cytoplasm stimulate the 
generation of stress-mediated radicals. These enzymes degrade the material ingested in 
the  phagocytic  vacuole  which  is  due  to  production  of  immune  complexes.  This 
complex leads to release of certain factors that leads to membrane damage by attracting 
leukocytes thereby releasing the lysosomal enzymes (T.Guardia et al, 2001). Elevated 
lysosomal  enzymes  in  the  extracellular  fluid occur  because of  decreased  lysosomal 
membrane stability  (Surinder Kumar yogeeta et  al,  2006,). Lysosomal enzymes like 
betaglucuronidase;  N-acetylglucosaminidase;  acidphosphatase,  and cathepsin-D were 
found to be closely related with RA (A.F.Safina et al 1992). Betaglucuronidase in the 
serum acts as an immediate indicator to check the extent of effectiveness of drugs in 
RA conditions (A Falkenbach et al, 86, (1991).The activities of serum acid hydrolases 
is  increased  in  CFA induce  arthritis  rats  (Yasuda  et  al,  2000). The  finding  shows 
increased  levels  of  N-acetylglucosaminidase  (NAG),  betaglucuronidase, 
acidphosphatase, and cathepsin-D in CFA induced arthritis rats may be due to the lipid 
deterioration of lysosomal membrane.  Several studies reported that flavonoid and β-
sitosterol play an important role in stabilization of lysosomal Membrane (Jagetia et al, 
2002,). It has been well proved that ursolic acid posses membrane stabilization activity 
(Han et al 1997, Balaneehru and Nagarajan et al 1992,).  The pre treatment of GFA 
shows  the  reduced  levels  of  lysosomal  enzymes  by  the  presence  of  these 
phytoconstituents may be responsible for decrease the level of lysosomal enzyme and 
helps in maintains of structural integrity of cell membrane in CFA induce arthritis.
Cumulative studies showed that in arthritic conditions neutrophils impart in the 
production of Reactive Oxygen species by amplifying the activities of lymphocytes and 
macrophages (Nurcombe et al, 1991). Neutrophils also increase the levels of cytokines 
(TNF-α,  IL-6)  by  proliferation  of  synoviocytes  (O’Reilly  MS,  1997,  et  al),  which 
ultimately generates H2O2 by fibroblasts and Chondriocytes (Tiku et al, 1990,). Ample 
literature prostrated that oxygen derived free radicals modulate the level of cytokines 
(TNF-α) (Meier B, et al 1989,).Reports imply that the pathogenesis of RA is brought 
about by the activity of a complicated network of cytokines (Choy and Panayi, 2001). 
TNF-  α  and  IL-6  are  acknowledged  to  be  the  primary  cytokines  responsible  for 
mediating the marked destruction of cartilage and bone in arthritis (Carteron, 2000). 
Literature data suggest that CFA induced RA has been shown an enhanced levels of 
TNF-α in plasma which leads to simultaneous increase in superoxide ions  thereby 
increasing the intensity of oxidative stress (Miesel et al, 1996 a,b). Enhanced levels of 
TNF-  α  stimulate  the  generation  of  other  cytokines,  induce  endothelial  adhesion 
molecules,  stimulate  collagenase  and  excite  osteoclast  differentiation  (Bazzoni  and 
Beutler, 1996 ;). This leads to activation of the collagenase enzymes and disturbs the 
integrity of collagen, which grounds for decrease in the collagen levels and therefore 
leads to cartilage destruction (Schuna A, A, et al 2000; Geetha T, et al 1999) as well as 
it  helps in  enhancing the activity of bone resorption (Ralston & Grabowski,  1996). 
Hence,  the  obstruction  of  TNF-  α  has  an  added  effect  on  inflammation  than  the 
blockade of other cytokines.
Substantial  evidence  stated  that  increased  levels  of  cytokines  implies  the 
generation  of  nitric  oxide  radicals  by  activation  of  inducible  nitric  oxide  synthase 
(Rediske  et  al,  1994,  Sakurai  et  al,  1995,  Perkins  et  al,  1998,  Stichtenoth  Frolich, 
1998).  The  generated  nitric  oxide  radical  react  with  super  oxide  ions  leads  to  the 
formation of peroxynitrates  which is a potent oxidant leads to significant nitration of 
tyrosine residue,  protein and lipid destruction indicate lipid peroxidation (Beckman et 
al  1994,  Pryor  WA  et  al  1995,  Ischiropoulos  H  et  al  1992;).  It  has  been  well 
documented that arthritis  induced by CFA leads to production of cytokines such as 
TNF-α and  IL-6  which  may be  activation  of  transcription  factors  or  generation  of 
oxygen-derived  free  radicals  (Morel  Baroiki,  1998,  Chen  et  al,  1999).  This  was 
observed in  current  study on CFA induced arthritis  shows the accelerated levels  of 
TNF-α and IL-6. Several studies report that both β-sitosterol and Ursolic acid act as 
antioxidants,  which  have  potent  anti-inflammatory  activities  and help to  reduce  the 
levels  of pro-inflammatory cytokines (Gupta MB et al 1996, Bouic PJD et al  1999, 
Chattopadhyay D et al, 2005, Arunachalam G et al, 2002; Chattopadhyay D et al 2002). 
In  current  study deleterious  effect  was  conquered  over  CFA induced  RA after  the 
treatment with GF, which is due to its anti-inflammatory activity of phyto-constituents 
such as β-sitosterol, and ursolic acid, which is already reported.
Glycoproteins are protein carbohydrate-linked active macromolecules present in 
the cells in both soluble and membrane-bound forms. Aggumented reports stated that it 
plays  an  important  role  in  secretion  and  absorption  of  macromolecules,  cell 
differentiation and signal transduction among cells (Mittal et al., 1996). Substational 
reports suggest that glycoprotein and glycoaminoglycans are responsible in maintaining 
the structural firmness of collagen fibrils (D.S.Jackson et al 1968,). The increase in the 
levels of glycoproteins (hexose, hexosamine, and sialic acid) occurs in case of adjuvant 
induced arthritis  as well  as in the case of inflammation which may be attributed to 
connective-tissue-activating  factor is observed in CFA induce rats  in agreement with 
previous reports (Caster et al., 1958). Treatment with GF extract however proved to be 
beneficial in lowering the enhanced levels of glycoproteins to normalcy which may be 
due to the presence of several phyto-constituents.
SUMMARY AND CONCLUSION
To summarize, these finding of this current exploration suggest the excessive 
free radical imposed stress by CFA induce arthritis resulted in bone erosion, lysosomal 
damage  and  increase  serum  pro-inflammatory  cytokines  levels  In  contrast,  GF 
treatment regain the  lysosomal structural integrity and anti-inflammatory effect. This 
sumpshot shows the light on the fact that GF might be beneficial in the stress condition 
implied by CFA induce arthritis.
             Concluding our study  GF treatment regains the liver  lysosomal structural 
integrity and anti-inflammatory effect induced by CFA induced arthritis in rat.
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TABLES AND FIGURES
Table-1: Effect of CFA and GF on body and tibia weight in control and experimental animals
Groups Group I(Control)
Group II
(CFA Induced)
Group III
(GF extract alone)
Group IV
(CFA+GF 200mg/
kg)
Find body weight 
(gm) 141.32±7.83 111.11±4.86
*a 141.64±6.25NS 132.70±6.08*b
Whole Tibia weight 
(mg) 256.23±9.14 200.82±6.17
*a 255.83±8.65NS 237.65±7.34*b
            Values are expressed as mean ± S.D. for six animals.
a= Comparison are made between Group-I and Group-II; 
b= Comparison are made between Group-II with Group-IV. 
 * represent the statistical significance at p < 0.05
 NS represents non-significance at p < 0.05.
         
Table-2: Effect of CFA and GF on Lysosomal enzymes in liver of control and experimental animals
Groups β-D-glucuronidase Acid phosphatase
β-D-N-acetyl 
glucosaminidase Cathepsin-D
Group-І 
(Control) 8.52±0.26 92.20±3.18 22.49±1.27 24.45±1.44
Group-ІІ 
(CFA Induced) 20.21±0.01
*a 174.51±4.70*a 40.44±0.03*a 49.31±2.96*a
Group-ІІІ
(GF extract alone) 8.53±0.22
NS 91.73±4.06NS 23.33±1.03NS 24.20±1.71NS
Group-ІV 
(CFA+GF, 200mg/
kg)
11.61±0.89*b 110.30±2.79*b 29.76±1.67*b 30.44±2.28*b
Values are expressed as mean ± S.D. for six animals. Units:  β-D-glucuronidase (µmoles of tyrosine 
liberated/ h/100 mg protein); Acid phosphatase (IU/l for serum and µmoles of phenol liberated); β-D-
N-acetyl glucosaminidase (µmoles of p-nitrophenol liberated/h/mg protein); Cathepsin-D (µmoles 
of tyrosine liberated/ h/100 mg protein). 
a=Comparison are made between Group-I and Group-II; 
b= Comparison are made between Group-II with Group-IV. 
 * represent the statistical significance at p < 0.05 
 NS represents non-significance at p < 0.05.
Table-3: Effect of CFA and GF on Glycoproteins in liver of control and experimental animals
Groups Hexose Hexosamine Sailic acid
Group-І (Control) 145.31±7.13 0.22±0.006 38.09±4.56
Group-ІІ 
(CFA Induced) 181.87±9.81
*a 0.42±0.014*a 59.43±3.71*a
Group-ІІІ
(GF extract alone) 145.18±5.08
NS 0.22±0.014 NS 39.62±3.73NS
Group-ІV 
(CFA+GF 
200mg/kg)
150.40±4.85*b 0.28±0.010*b 41.98±3.63*b
Values  are expressed as  mean ±  S.D.  for six  animals.  Units:  Hexose (Units  mg/100mg protein); 
Hexoseamine (Units mg/g protein); Sailic acid (Units mg/g protein). 
a=Comparison are made between Group-I and Group-II;
b= Comparison are made between Group-II with Group-IV. 
* represent the statistical significance at p < 0.05  
NS represents non significance at p < 0.05.
FIGURE-10: Effect of CFA and GF on TNF-α level in serum of control and 
experimental animals
Values are expressed as mean ± S.D. for six animals. Units: TNF-α (ng/mg 
protein); 
a=Comparison are made between Group-I and Group-II.
b= Comparison are made between Group-II with Group-IV. 
* represent the statistical significance at p < 0.05.
NS- represents non-significance at p < 0.05.
FIGURE-11: Effect of CFA and GF on IL-6 level in serum of control and 
experimental animals
Values are expressed as mean ± S.D. for six animals. Units:  IL-6  (ng/mg 
protein); 
 a = Comparison are made between Group-I and Group-II.
 b = Comparison are made between Group-II with Group-IV. 
* represent the statistical significance at p < 0.05.
NS represents non-significance at p < 0.05.
PLATE-1: HISTOPATHOLOGICAL EXAMINATION OF INTERPHALANGEAL 
JOINTS IN CONTROL AND EXPERIMENTAL ANIMALS
            
  Figure-12: (Group-I) Control                    Figure-13: (Group-II) CFA Induced 
Figure-14: (Group-IV) CFA induced and GF extract treated (200mg/kg)
                                    
Plate II: X-RAY STUDY OF RAT FOOT REGION IN CONTROL AND 
EXPERIMENTAL ANIMALS
  
Figure-15: (Group-I) Control                            Figure-16: (Group-II) CFA Induced 
Figure-17: (Group-IV) GF Extract Alone                 Figure-18: CFA Induced and 
  GF Extract Treated (200mg/kg)
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